Skip to main content
Livermore
Livermore
ZHEN

King Wealth

SEC CIK
0001568235
Latest filing
Aug 5, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by King Wealth, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
4,000
Value
$490.0K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of PTGX by King Wealth, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,000$490.0K0.1%00.0%UnchangedHolders
Q1 20264,000$422.0K0.1%00.0%UnchangedHolders
Q4 20254,000$349.0K<0.1%−2,000−33.3%ReducedHolders
Q3 20256,000$399.0K0.1%00.0%UnchangedHolders
Q2 20256,000$332.0K<0.1%00.0%UnchangedHolders
Q1 20256,000$290.0K<0.1%00.0%UnchangedHolders
Q4 20246,000$232.0K<0.1%00.0%UnchangedHolders
Q3 20246,000$270.0K<0.1%−6,000−50.0%ReducedHolders
Q2 202412,000$416.0K0.1%00.0%UnchangedHolders
Q1 202412,000$347.0K0.1%00.0%UnchangedHolders
Q4 202312,000$275.0K0.1%00.0%UnchangedHolders
Q3 202312,000$200.0K<0.1%00.0%UnchangedHolders
Q2 202312,000$331.0K0.1%00.0%UnchangedHolders
Q1 202312,000$276.0K0.1%−10,000−45.5%ReducedHolders
Q4 202222,000$240.0K0.1%00.0%UnchangedHolders
Q3 202222,000$185.0K<0.1%00.0%UnchangedHolders
Q2 202222,000$174.0K<0.1%00.0%UnchangedHolders
Q1 202222,000$521.0K0.1%00.0%UnchangedHolders
Q4 202122,000$752.0K0.1%00.0%UnchangedHolders
Q3 202122,000$390.0K0.1%00.0%UnchangedHolders
Q2 202122,000$987.0K0.2%00.0%UnchangedHolders
Q1 202122,000$570.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.